Rasopathies case report: concurrence of two pathogenic variations de novo in NF1 and KRAS genes in a patient

被引:3
作者
Baquedano Lobera, Irene [1 ]
Izquierdo Alvarez, Silvia [2 ]
Jesus Olivan del Cacho, Maria [3 ]
机构
[1] Miguel Servet Childrens Hosp, Dept Pediat, Isabel la Catolica Ave 1-3, Zaragoza 50009, Spain
[2] Miguel Servet Hosp, Dept Clin Biochem, Clin Genet & Assisted Reprod, Padre Arrupe St, Zaragoza 50009, Spain
[3] Miguel Servet Childrens Hosp, Dept Neonatol, Isabel la Catolica Ave 1-3, Zaragoza 50009, Spain
关键词
Neurofibromatosis; 1; Noonan syndrome; Mutation; Ras-MAPK pathway; Signal transduction pathway; RASopathies; Case report; NEUROFIBROMATOSIS TYPE-1; INHIBITION; CANCER; RAS; MEK;
D O I
10.1186/s12887-019-1463-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundRasopathies are a group of genetic malformative syndromes including neurofibromatosis 1, Noonan, LEOPARD, Costello, cardio-facio-cutaneous, Legius, and capillary malformation-arteriovenous malformation syndromes.Case presentationWe present a female newborn that consulted at the emergency department with refusal to eat and sleepiness. A shortened femur, thickened nucal fold and suspect for agenesis of the corpus callosum were observed in prenatal ultrasound. Her phenotype included hypertelorism, antimongoloid obliquity of the palpebral fissure, prominent forehead, long filtrum, thickened nucal fold, separated nipples, widespread thickened skinfolds and cafe-au-lait spots. She had a systolic murmur due to pulmonary valve stenosis. The NF1 gene testing found the pathogenic variant p.E2586X (c.7756G>T) in exon 53, not described in any international database or scientific publications yet. Also, a mutation in the Kras gene was detected (p.Val14lle), which is associated with mild Noonan phenotype. Both variations were de novo.ConclusionsNot all genes and mutations have already been discovered, so it's important to document new findings, like our patient's, to enrich and update the international database and broaden all possible knowledge about rasopathies. This is the first case to be described presenting simultaneously two mutations in Kras and NF1 genes, whose possible synergic effect regarding its pathogenicity is unknown, but could be interesting towards therapeutic alternatives.
引用
收藏
页数:4
相关论文
共 13 条
[1]   Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish [J].
Anastasaki, Corina ;
Rauen, Katherine A. ;
Patton, E. Elizabeth .
DISEASE MODELS & MECHANISMS, 2012, 5 (04) :546-552
[2]   The RAS/MAPK syndromes: Novel roles of the RAS pathway in human genetic disorders [J].
Aoki, Yoko ;
Niihori, Tetsuya ;
Narumi, Yoko ;
Kure, Shigeo ;
Matsubara, Yoichi .
HUMAN MUTATION, 2008, 29 (08) :992-1006
[3]   Recent advances in RASopathies [J].
Aoki, Yoko ;
Niihori, Tetsuya ;
Inoue, Shin-ichi ;
Matsubara, Yoichi .
JOURNAL OF HUMAN GENETICS, 2016, 61 (01) :33-39
[4]   Neurofibromatosis-Noonan syndrome: Molecular evidence of the concurrence of both disorders in a patient [J].
Bertola, DR ;
Pereira, AC ;
Passetti, F ;
de Oliveira, PSL ;
Messiaen, L ;
Gelb, BD ;
Kim, CA ;
Krieger, JE .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2005, 136A (03) :242-245
[5]   Next-generation sequencing identifies rare variants associated with Noonan syndrome [J].
Chen, Peng-Chieh ;
Yin, Jiani ;
Yu, Hui-Wen ;
Yuan, Tao ;
Fernandez, Minerva ;
Yung, Christina K. ;
Trinh, Quang M. ;
Peltekova, Vanya D. ;
Reid, Jeffrey G. ;
Tworog-Dube, Erica ;
Morgan, Margaret B. ;
Muzny, Donna M. ;
Stein, Lincoln ;
McPherson, John D. ;
Roberts, Amy E. ;
Gibbs, Richard A. ;
Neel, Benjamin G. ;
Kucherlapati, Raju .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (31) :11473-11478
[6]   Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674
[7]   RASopathies: unraveling mechanisms with animal models [J].
Jindal, Granton A. ;
Goyal, Yogesh ;
Burdine, Rebecca D. ;
Rauen, Katherine A. ;
Shvartsman, Stanislav Y. .
DISEASE MODELS & MECHANISMS, 2015, 8 (08) :769-U403
[8]   Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1 - A randomized controlled trial [J].
Krab, Lianne C. ;
de Goede-Bolder, Arja ;
Aarsen, Femke K. ;
Pluijm, Saskia M. F. ;
Bouman, Marlies J. ;
van der Geest, Jos N. ;
Lequin, Maarten ;
Catsman, Coriene E. ;
Arts, Willem Frans M. ;
Kushner, Steven A. ;
Silva, Alcino J. ;
de Zeeuw, Chris I. ;
Moll, Henriette A. ;
Elgersma, Ype .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (03) :287-294
[9]   SELECTIVE INHIBITION OF EXTRACELLULAR SIGNAL-REGULATED KINASES 1/2 BLOCKS NERVE GROWTH FACTOR TO BRAIN-DERIVED NEUROTROPHIC FACTOR SIGNALING AND SUPPRESSES THE DEVELOPMENT OF AND REVERSES ALREADY ESTABLISHED PAIN BEHAVIOR IN RATS [J].
Matsuoka, Y. ;
Yang, J. .
NEUROSCIENCE, 2012, 206 :224-236
[10]   A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor [J].
Ratner, Nancy ;
Miller, Shyra J. .
NATURE REVIEWS CANCER, 2015, 15 (05) :290-301